Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer

Wang,Linlin; Geng,Ting; Guo,Xiaosun; Liu,Jie; Zhang,Pei; Yang,Dong; Li,Juan; Yu,Shuwen; Sun,Yuping

doi:10.3892/mmr.2014.3029

Co-expression of immunoglobulin-like transcript 4 and angiopoietin-like proteins in human non-small cell lung cancer

Authors:
- Linlin Wang
- Ting Geng
- Xiaosun Guo
- Jie Liu
- Pei Zhang
- Dong Yang
- Juan Li
- Shuwen Yu
- Yuping Sun
View Affiliations

Affiliations: Department of Oncology, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China, Department of Oncology, Weifang Medical University, Weifang, Shandong 261053, P.R. China, Department of Pathophysiology, Medicine School of Shandong University, Jinan, Shandong 250012, P.R. China, Department of Pharmacy, Jinan Central Hospital Affiliated to Shandong University, Jinan, Shandong 250013, P.R. China
Published online on: December 2, 2014 https://doi.org/10.3892/mmr.2014.3029
Pages: 2789-2796

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

The development of strategies for the inhibition of non‑small cell lung cancer (NSCLC) progression and metastasis have been mainly unsuccessful, in part due to insufficient mechanistic understanding of the disease. In the current study, the critical role of the co‑expression of immunoglobulin‑like transcript 4 (ILT4) and its ligands, angiopoietin‑like proteins (ANGPTLs), in the development of NSCLC was demonstrated. ILT4 and ANGPTL2 or ANGPTL5 were found to be co‑expressed in the five NSCLC cell lines that were investigated at the mRNA and protein level. Upon up‑ or downregulation of ILT4, the expression of ANGPTL2 was increased or reduced, respectively, while the expression of ANGPTL5 was unaffected. The co‑expression of ILT4 and ANGPTL2/ANGPTL5 was detected in human primary NSCLC tissues using immunohistochemical analysis. In total, 114 lung cancer specimens were included in the study; high expression of ILT4, ANGPTL2 and ANGPTL5 was observed in 58.8, 45.6 and 55.3%, respectively. The expression of ILT4 was found to be significantly correlated with a high expression level of ANGPTL2 (R=0.466, P=0.004); however, it was not correlated with the expression of ANGPTL5 (R=0.142, P=0.131). In ILT4‑positive samples, cases with ANGPTL2‑positive expression levels presented greater levels of lymph node metastasis (P=0.011) and shorter overall survival times (P=0.045). In addition, cases with ANGPTL5‑positive expression presented poor overall survival rates (P=0.040). By contrast, in the ILT4‑negative cases, no statistically significant differences were identified in the overall survival rates between samples with high and low expression of ANGPTL2 or ANGPTL5. In conclusion, the present study demonstrated the presence of interaction among ILT4 and ANGPTLs, which may be important in NSCLC progression. Therefore, the blockade of ANGPTLs or ILT4 may be an effective therapeutic approach for NSCLC treatment.

View Figures

View References

1	Postmus PE: Chemotherapy for non-small cell lung cancer: the experience of the Lung Cancer Cooperative Group of the European Organization for Research and Treatment of Cancer. Chest. 113(Suppl): 28S–31S. 1998. View Article : Google Scholar : PubMed/NCBI
2	Fanger NA, Cosman D, Peterson L, Braddy SC, Maliszewski CR and Borges L: The MHC class I binding proteins LIR-1 and LIR-2 inhibit Fc receptor-mediated signaling in monocytes. Eur J Immunol. 28:3423–3434. 1998. View Article : Google Scholar : PubMed/NCBI
3	Borges L and Cosman D: LIRs/ILTs/MIRs, inhibitory and stimulatory Ig-superfamily receptors expressed in myeloid and lymphoid cells. Cytokine Growth Factor Rev. 11:209–217. 2000. View Article : Google Scholar : PubMed/NCBI
4	Colonna M, Samaridis J, Cella M, et al: Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J Immunol. 160:3096–3100. 1998.PubMed/NCBI
5	Colonna M, Navarro F, Bellón T, et al: A common inhibitory receptor for major histocompatibility complex class I molecules on human lymphoid and myelomonocytic cells. J Exp Med. 186:1809–1818. 1997. View Article : Google Scholar
6	de Waal Malefyt R, Haanen J, Spits H, et al: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigen-specific human T cell proliferation by diminishing the antigen-presenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Exp Med. 174:915–924. 1991. View Article : Google Scholar : PubMed/NCBI
7	Lepin EJ, Bastin JM, Allan DS, et al: Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur J Immunol. 30:3552–3561. 2000. View Article : Google Scholar
8	Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J and Carosella ED: HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol. 166:5018–5026. 2001. View Article : Google Scholar : PubMed/NCBI
9	Manavalan JS, Rossi PC, Vlad G, et al: High expression of ILT3 and ILT4 is a general feature of tolerogenic dendritic cells. Transpl Immunol. 11:245–258. 2003. View Article : Google Scholar : PubMed/NCBI
10	Sun Y, Liu J, Gao P, Wang Y and Liu C: Expression of Ig-like transcript 4 inhibitory receptor in human non-small cell lung cancer. Chest. 134:783–788. 2008. View Article : Google Scholar : PubMed/NCBI
11	Zheng J, Umikawa M, Cui C, et al: Inhibitory receptors bind ANGPTLs and support blood stem cells and leukaemia development. Nature. 485:656–660. 2012. View Article : Google Scholar : PubMed/NCBI
12	Tabata M, Kadomatsu T, Fukuhara S, et al: Angiopoietin-like protein 2 promotes chronic adipose tissue inflammation and obesity-related systemic insulin resistance. Cell Metab. 10:178–188. 2009. View Article : Google Scholar : PubMed/NCBI
13	Zhang CC, Kaba M, Ge G, et al: Angiopoietin-like proteins stimulate ex vivo expansion of hematopoietic stem cells. Nat Med. 12:240–245. 2006. View Article : Google Scholar : PubMed/NCBI
14	Hato T, Tabata M and Oike Y: The role of angiopoietin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 18:6–14. 2008. View Article : Google Scholar : PubMed/NCBI
15	Oike Y, Yasunaga K and Suda T: Angiopoietin-related/angiopoietin-like proteins regulate angiogenesis. Int J Hematol. 80:21–28. 2004. View Article : Google Scholar : PubMed/NCBI
16	Aoi J, Endo M, Kadomatsu T, et al: Angiopoietin-like protein 2 is an important facilitator of inflammatory carcinogenesis and metastasis. Cancer Res. 71:7502–7512. 2011. View Article : Google Scholar : PubMed/NCBI
17	Sasaki H, Suzuki A, Shitara M, et al: Angiopoietin-like protein ANGPTL2 gene expression is correlated with lymph node metastasis in lung cancer. Oncol Lett. 4:1325–1328. 2012.PubMed/NCBI
18	Kikuchi R, Tsuda H, Kozaki K, et al: Frequent inactivation of a putative tumor suppressor, angiopoietin-like protein 2, in ovarian cancer. Cancer Res. 68:5067–5075. 2008. View Article : Google Scholar : PubMed/NCBI
19	Teicher BA: Searching for molecular targets in sarcoma. Biochem Pharmacol. 84:1–10. 2012. View Article : Google Scholar : PubMed/NCBI
20	Endo M, Nakano M, Kadomatsu T, et al: Tumor cell-derived angiopoietin-like protein ANGPTL2 is a critical driver of metastasis. Cancer Res. 72:1784–1794. 2012. View Article : Google Scholar : PubMed/NCBI
21	Drake AC, Khoury M, Leskov I, et al: Human CD34⁺ CD133⁺ hematopoietic stem cells cultured with growth factors including Angptl5 efficiently engraft adult NOD-SCID Il2rγ−/− (NSG) mice. PLoS One. 6:e183822011. View Article : Google Scholar
22	Khoury M, Drake A, Chen Q, Dong D, Leskov I, et al: Mesenchymal stem cells secreting angiopoietin-like-5 support efficient expansion of human hematopoietic stem cells without compromising their repopulating potential. Stem Cells Dev. 20:1371–1381. 2011. View Article : Google Scholar :
23	Miida T and Hirayama S: Impacts of angiopoietin-like proteins on lipoprotein metabolism and cardiovascular events. Curr Opin Lipidol. 21:70–75. 2010. View Article : Google Scholar
24	Sobin LH, Gospodarowicz MK and Wittekind C: TNM Classification of Malignant Tumors. 7th edition. John Wiley & Sons; Hoboken, NJ: 2009
25	Huang XF, Han J, Hu XT and He C: Mechanisms involved in biological behavior changes associated with Angptl4 expression in colon cancer cell lines. Oncol Rep. 27:1541–1547. 2012.PubMed/NCBI
26	Marchiò S, Soster M, Cardaci S, et al: A complex of α6 integrin and E-cadherin drives liver metastasis of colorectal cancer cells through hepatic angiopoietin-like 6. EMBO Mol Med. 4:1156–1175. 2012. View Article : Google Scholar
27	Hato T, Tabata M and Oike Y: The role of angiopoitin-like proteins in angiogenesis and metabolism. Trends Cardiovasc Med. 18:6–14. 2008. View Article : Google Scholar : PubMed/NCBI
28	Sporn MB and Roberts AB: Autocrine growth factors and cancer. Nature. 313:745–747. 1985. View Article : Google Scholar : PubMed/NCBI